Takeda Pharmaceutical Company Limited Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used
Takeda Pharmaceutical Company Limited (TKPHF) reported Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used of JPY 4.16 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed · last filed 2025-06-25
| Period end | Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used 12 month |
|---|---|
| 2025-03-31 | 4.16B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 4.31B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 4.52B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 4.46B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 4.80B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 5.77B JPY 20-F · filed 2022-06-29 |